Live feed
Filing
SC 13D/A
SC 13D/A0000919574-22-002416·BROADWOOD PARTNERS, L.P.
Schedule 13D ownership disclosure
Lineage Cell Therapeutics Inc
Security class unavailable · CUSIP: 53566P109
Event date: 2022-03-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 20.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-22-002416
- Form type
- SC 13D/A
- Filer
- BROADWOOD PARTNERS, L.P.
- CIK
- CIK 1278386
- Filed
- Mar 25, 2022
- Reporting period
- Mar 10, 2022
- Description
- Schedule 13D beneficial ownership